Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease multiple endocrine neoplasia type 1
Comorbidity C0006142|breast cancer
Sentences 74
PubMedID- 22481980 We conducted a single institution phase ii study to assess the efficacy and safety of neoadjuvant tec regimen in patients with locally advanced breast cancer.
PubMedID- 24771923 Aim: around half of all women in germany with breast cancer are older than 65 and approximately one third of them is older than 70 years of age.
PubMedID- 25520075 breast cancer, a leading cause of death among women in most countries worldwide, is rapidly increasing in incidence in vietnam.
PubMedID- 24959251 To the best of our knowledge, there have been two reports of men1 associated with breast cancer regardless of brca1/2 germline mutations (12,13).
PubMedID- 26008800 However, the association between pahs and breast cancer in women is unclear.
PubMedID- 20528235 Similarly, while breast cancer in women is diagnosed at an increasingly early stage, male breast cancer is usually diagnosed late, when the chances of cure are diminished.
PubMedID- 24678379 Upper panel: the percentage of women initiallydiagnosed with advanced stage breast cancer (defined as the sum of thepercentages of regional and distant disease initial diagnoses over the years2005 through 2009) calculated from mississippi cancer registry data for eachof the nine public health districts (http://mcr.umc.edu/documents/femalebreastphddatacombinedyears20052009new.pdf),then plotted against the ordinate.
PubMedID- 22310341 Efficacy of the cmfvp regimen in patients with metastatic breast cancer previously treated with anthracycline and taxane.
PubMedID- 24261383 Only 8% (3/39) of the women in their 40s with screening-detected breast cancer had a first-degree relative with breast cancer.
PubMedID- 22642448 breast cancer in men is rare, and clinical trials are thus not feasible.
PubMedID- 23909038 breast cancer in men is 100 times less common than in women.
PubMedID- 22869054 We assessed pooled data from two phase iii studies to investigate the potential effect of age on outcome of a dexamethasone-sparing regimen in women with breast cancer undergoing a highly emetogenic ac combination [9, 10].
PubMedID- 25421784 We calculated cumulative hazard rates for breast cancer in women in cohorts defined by age at entry and number of negative screens for the maximum follow-up period in each screening centre.
PubMedID- 23483369 The number of men involved with breast cancer was 172 (2.8%) of all cases.
PubMedID- 25413699 In the trials that achieved a 20% or greater reduction in advanced stage disease, there was an average breast cancer mortality reduction of 28% among women invited to screening (attenders and nonattenders combined).
PubMedID- 26457327 Background: the global burden of breast cancer in women is substantial and increasing.
PubMedID- 20947484 Objectives: our aim was to evaluate the cost-effectiveness of docetaxel versus weekly paclitaxel regimen in patients with metastatic breast cancer previously treated with anthracycline from the spanish national health service (nhs) perspective.
PubMedID- 21069675 Objectives: to assess the effects of adding one or more chemotherapy drugs to an established regimen in women with metastatic breast cancer.
PubMedID- 21170814 Factors associated with delays to diagnosis and treatment of breast cancer in women in a louisiana urban safety net hospital.
PubMedID- 25112235 breast cancer in men is much less common than benign gynaecomastia, and the two conditions can usually be distinguished by a careful physical examination.
PubMedID- 20981261 One out of five omani women is diagnosed with breast cancer in her lifetime, and the age-standardized incidence rate is 15.6 per 100,000. in our last reported study, we found that age at diagnosis is younger in oman than in the western world, and the majority of patients present at advanced stages of disease (iii and iv) [1].
PubMedID- 21682886 Data from the usa indicated that the breast cancer screening rates of women in lower sociodemographic status were low, and that their morbidity and death rates have not been reduced [11-15].
PubMedID- 21679005 First, a pilot safety study of the regimen in 13 patients with breast cancer was conducted, which demonstrated promising efficacy (own unpublished data).
PubMedID- 20179808 A population-based survey comparing women having breast cancer with women in the general population determined that breast cancer survivors were 5.3 times more likely than women in the general population to experience menopausal symptoms6.
PubMedID- 21222418 Epidemiology of breast cancer in women in jordan: patient characteristics and survival analysis.
PubMedID- 22701186 For the combined number of 23 women in both studies with stage i–iii breast cancer status after breast surgery and chemotherapy who then received radiotherapy, lymphocytes were within normal limits before rt but dropped to abnormally low levels after rt.
PubMedID- 25356184 breast cancer in men is a rare cancer manifestation.
PubMedID- 21086703 The epidemiologic evidence of a relationship between shift and night work and breast cancer in women is based upon nine studies, six of which suggest a moderately increased risk to develop breast cancer after prolonged exposure to shift and night work.
PubMedID- 22007238 breast cancer in men is uncommon, and even more rare is the simultaneous presentation of two different malignancies.
PubMedID- 25296018 Classic markers for breast cancer in women include estrogen and progesterone receptor steroid hormone proteins and human epidermal growth factor receptor 2.
PubMedID- 24010672 These 37 women included 31 with prior er-positive breast cancer and 6 women with prior er-negative breast cancer.
PubMedID- 22737442 Background: although breast cancer in men is uncommon, its incidence rate has an increasing trend.
PubMedID- 22767683 breast cancer in men is rare.
PubMedID- 24761803 Estrogen and progesterone receptor status in breast cancer: a cross-sectional study of 450 women in kerala, south india.
PubMedID- 24460269 breast cancer awareness of rural women in malaysia: is it the same as in the cities.
PubMedID- 25835055 breast cancer in women in their thirties (2007-2013): a retrospective review.
PubMedID- 24352641 Finn and colleagues identify low er levels as a biomarker predicting benefit from the addition of the egfr/her2 dual inhibitor lapatinib to an antiestrogen treatment regimen in patients with metastatic er(+)/her2(-) breast cancer.
PubMedID- 25245129 Despite being in an urban region, a significant number of women in nj with early-stage breast cancer did not receive bcs.
PubMedID- 23551959 breast cancer survival of hispanic women in the usa is influenced by country of origin.
PubMedID- 21501481 Therefore, treating subtype iv breast cancer with anthracycline-containing regimen is critical.
PubMedID- 24298381 This study was performed to assess the association of hla class i alleles with breast cancer in women in southern iran.
PubMedID- 25929887 Erratum to: breast cancer screening of underserved women in the usa: results from the national breast and cervical cancer early detection program, 1998-2012.
PubMedID- 24416691 Breast biopsies for 7332 women indicated 23.3% with invasive breast cancer, 6.7% with ductal carcinoma in situ, and 70.0% with nonmalignant diagnoses that would not have been further di ff erentiated by administrative codes alone.
PubMedID- 21446609 Testing the feasibility of a culturally tailored breast cancer screening intervention with native hawaiian women in rural churches.
PubMedID- 25556451 Correlation between selected xrcc2, xrcc3 and rad51 gene polymorphisms and primary breast cancer in women in pakistan.
PubMedID- 22377278 Conclusion: this study has shown that breast cancer is a disease of young women in yemen.
PubMedID- 20677038 Many women in kenya with breast cancer symptoms do not seek medical attention until their cancer is very advanced, leading to high mortality rates and a heavy cancer burden on the nation.
PubMedID- 26237063 This trial demonstrated that the skeletal morbidity rate (smr) was numerically very similar (but statistically non-inferior) in the group of patients who had their zoledronic acid treatment de-escalated to every 12 weeks, as opposed to maintaining it at every four weeks after at least one year of prior treatment, i.e., a less-intensive treatment regimen was equivalent to the standard regimen in women with breast cancer and bone metastases for the primary study endpoint.
PubMedID- 24560120 Conclusions: the equitable access to cancer treatment and other health services provided by whmp to low-income, uninsured women in georgia with breast cancer makes it a critical health care safety net program in georgia, the need for which will continue through the implementation of the affordable care act.
PubMedID- 24101169 Objective: to determine the false-negative rate (fnr) for sln surgery following chemotherapy in women initially presenting with biopsy-proven cn1 breast cancer.

Page: 1 2